(Total Views: 472)
Posted On: 01/13/2021 12:27:42 PM
Post# of 145249
![](/m/assets/46931549/no_avatar_available_thumb.jpg)
How about a PR announcing the unblinding, and then adding the eIND continuation and the open label extension for our s/c trial, and then adding some results from our current eIND and open label extension???
Nader does hate the shorts almost as much as I go, so the above PR after market close, could help.
Nader does hate the shorts almost as much as I go, so the above PR after market close, could help.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)